1. Home
  2. VYNE vs DAIO Comparison

VYNE vs DAIO Comparison

Compare VYNE & DAIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYNE
  • DAIO
  • Stock Information
  • Founded
  • VYNE 2003
  • DAIO 1969
  • Country
  • VYNE United States
  • DAIO United States
  • Employees
  • VYNE N/A
  • DAIO N/A
  • Industry
  • VYNE Biotechnology: Pharmaceutical Preparations
  • DAIO Electrical Products
  • Sector
  • VYNE Health Care
  • DAIO Industrials
  • Exchange
  • VYNE Nasdaq
  • DAIO Nasdaq
  • Market Cap
  • VYNE 24.3M
  • DAIO 22.0M
  • IPO Year
  • VYNE 2018
  • DAIO N/A
  • Fundamental
  • Price
  • VYNE $0.35
  • DAIO $3.31
  • Analyst Decision
  • VYNE Buy
  • DAIO Strong Buy
  • Analyst Count
  • VYNE 2
  • DAIO 2
  • Target Price
  • VYNE $8.00
  • DAIO $4.61
  • AVG Volume (30 Days)
  • VYNE 4.1M
  • DAIO 50.2K
  • Earning Date
  • VYNE 08-14-2025
  • DAIO 07-24-2025
  • Dividend Yield
  • VYNE N/A
  • DAIO N/A
  • EPS Growth
  • VYNE N/A
  • DAIO N/A
  • EPS
  • VYNE N/A
  • DAIO N/A
  • Revenue
  • VYNE $476,000.00
  • DAIO $22,732,000.00
  • Revenue This Year
  • VYNE $42.51
  • DAIO $9.52
  • Revenue Next Year
  • VYNE N/A
  • DAIO $5.84
  • P/E Ratio
  • VYNE N/A
  • DAIO N/A
  • Revenue Growth
  • VYNE N/A
  • DAIO N/A
  • 52 Week Low
  • VYNE $0.33
  • DAIO $1.88
  • 52 Week High
  • VYNE $4.30
  • DAIO $3.48
  • Technical
  • Relative Strength Index (RSI)
  • VYNE 29.46
  • DAIO 56.44
  • Support Level
  • VYNE $0.35
  • DAIO $3.20
  • Resistance Level
  • VYNE $0.36
  • DAIO $3.34
  • Average True Range (ATR)
  • VYNE 0.04
  • DAIO 0.13
  • MACD
  • VYNE -0.02
  • DAIO -0.01
  • Stochastic Oscillator
  • VYNE 1.79
  • DAIO 68.29

About VYNE VYNE Therapeutics Inc.

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.

About DAIO Data I/O Corporation

Data I/O Corp is a provider of programming, security deployment, security provisioning, and associated Intellectual Property protection and management solutions used in electronics manufacturing with flash memory, microcontrollers, and flash memory-based intelligent devices as well as secure element devices, authentication devices, and secure microcontrollers. It is engaged in focused on the design, manufacturing and sale of programming systems used by designers and manufacturers of electronic products. It has its geographic presence in the United States, Europe, and Asia and others. The company derives the majority of its revenue from Asia and others.

Share on Social Networks: